Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on Jul 18, 2019 2:39pm
70 Views
Post# 29936004

RE:RE:RE:Someone buying Canntrust?

RE:RE:RE:Someone buying Canntrust?
quietobserver wrote: Ya jumped .50 in the last half hour on almost 2M shares 
Alloparc wrote: I just read this too. Sounds more like the banks are testing waters than TRST actively looking, but who knows.
gottahunch wrote:
Early search for CannTrust buyer underway amid Health Canada probe: Sources https://www.bnn.ca/1.1289171

 


A buyer of TRST could salvage the 72000 patient business.  However the buyer would have to take on the risk of lawsuits from shareholders.  The buyer could arrange with the major shareholders  if the buyer takes over lawsuits will be dropped.  Also the buyer could arrange with HC that the licenses are not revoked under the new management and ownership.  The key for TRST is to act fast and salvage the 72000 patient business.   As for buyers that could pull this off the top ones are CRON and WEED.  They have cash.  CRON would be the most likely as they currently do not burn through much cash like WEED does. APHA could also be in the mix.  

Bullboard Posts